Anything is possible......this has happened even with the success of provenge to date.
J&J buys Cougar Biotech for $1B
By Maureen Martino Comment | Forward
Johnson & Johnson has snagged a biotech with a late-stage oncology drug in its pipeline. J&J will pay $1 billion cash for Los Angeles-based Cougar Biotechnology, which is developing drugs for prostate cancer, breast cancer and multiple myeloma. Cougar will work with Ortho Biotech Oncology R&D, a unit of Centocor R&D.
Cougar is conducting two Phase III trials for abiraterone acetate for prostate cancer. The first study involves patients with metastatic, castration-resistant prostate cancer who have progressed after docetaxel-based chemotherapy has failed. The second trial is testing patients who have not receive chemotherapy.
"The acquisition of Cougar Biotechnology with its talented team will strengthen our growing capabilities toward a leadership position in the global oncology market," said William N. Hait, M.D., Ph.D., Global Therapeutic Head, Oncology, Ortho Biotech Oncology Research & Development. "We are developing new treatments that we anticipate will change the course of cancer treatment by targeting the tumor and its microenvironment and thereby will provide a meaningful difference in the lives of millions of patients worldwide."
- Forums
- ASX - By Stock
- IMM
- worst corporate governance on the asx
worst corporate governance on the asx, page-82
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 33.5¢ | $55.35K | 163.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 52578 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 138526 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 21474 | 0.370 |
1 | 9692 | 0.350 |
1 | 28856 | 0.345 |
3 | 50135 | 0.340 |
4 | 39932 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 6404 | 1 |
0.330 | 2851 | 5 |
0.340 | 47750 | 2 |
0.350 | 66960 | 4 |
0.355 | 120377 | 5 |
Last trade - 10.04am 30/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online